ArticleNature communications2023

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models.

Chun Wai Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.